• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子-2与膀胱尿路上皮恶性肿瘤的侵袭潜能

Fibroblast Growth Factor-2 and the Invasive Potential in Urothelial Malignancies of the Bladder.

作者信息

Popov Hristo, Stoyanov George S, Ghenev Peter

机构信息

General and Clinical Pathology, Forensic Medicine and Deontology, Medical University of Varna, Varna, BGR.

General and Clinical Pathology, St. Marina University Hospital, Varna, BGR.

出版信息

Cureus. 2023 Jan 24;15(1):e34147. doi: 10.7759/cureus.34147. eCollection 2023 Jan.

DOI:10.7759/cureus.34147
PMID:36843751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9949347/
Abstract

Introduction Urothelial carcinomas represent a distinct group of malignancies with a high recurrence potential. Multiple studies have established a set of interactions between the tumor cells of urothelial neoplasms and the extracellular matrix regarding invasion and tumor progression. In the present study, we evaluated the expression of fibroblast growth factor-2 (FGF2) in early-stage urothelial carcinomas of the urinary bladder (pTa and pT1) regarding the invasive potential of these tumors. Materials and methods A retrospective non-clinical approach was utilized for the study. Tumor tissue sections used for the initial diagnosis were stained by immunohistochemical means with an anti-FGF2 antibody and the expression within the extracellular matrix was evaluated using a histo-score (h-score). Statistical parameters regarding tumor invasion, FGF2 expression pattern and levels, patient demographic characteristics, and disease recurrence were analyzed for significance. Results A total of 163 cases were analyzed, with an h-score of 110 determined as the optimal cut-off value for invasive potential regarding FGF2 expression, with a sensitivity of 75.4% and a specificity of 78.9%. No statistical correlation was established between the demographic profile of the patients and the occurrence of disease recurrence. Conclusion Based on our results, the study of tumor-extracellular matrix interactions in regards to FGF2 expression is a promising field, at least in urothelial malignancies of the urinary bladder, in regards to tumor invasive potential, while it remains unestablished how these interactions affect metastatic potential.

摘要

引言 尿路上皮癌是一组具有高复发潜能的独特恶性肿瘤。多项研究已经证实尿路上皮肿瘤的肿瘤细胞与细胞外基质之间在侵袭和肿瘤进展方面存在一系列相互作用。在本研究中,我们评估了成纤维细胞生长因子2(FGF2)在膀胱早期尿路上皮癌(pTa和pT1)中的表达情况,以了解这些肿瘤的侵袭潜能。材料与方法 本研究采用回顾性非临床研究方法。用于初始诊断的肿瘤组织切片用抗FGF2抗体进行免疫组织化学染色,并使用组织评分(h评分)评估细胞外基质中的表达情况。分析了与肿瘤侵袭、FGF2表达模式和水平、患者人口统计学特征以及疾病复发相关的统计参数的显著性。结果 共分析了163例病例,确定h评分为110作为FGF2表达侵袭潜能的最佳临界值,敏感性为75.4%,特异性为78.9%。患者的人口统计学特征与疾病复发的发生之间未建立统计学相关性。结论 根据我们的结果,关于FGF2表达的肿瘤-细胞外基质相互作用的研究是一个有前景的领域,至少在膀胱尿路上皮恶性肿瘤中,就肿瘤侵袭潜能而言,而这些相互作用如何影响转移潜能仍未明确。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9402/9949347/e8777331970c/cureus-0015-00000034147-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9402/9949347/18c618da0978/cureus-0015-00000034147-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9402/9949347/e8777331970c/cureus-0015-00000034147-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9402/9949347/18c618da0978/cureus-0015-00000034147-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9402/9949347/e8777331970c/cureus-0015-00000034147-i02.jpg

相似文献

1
Fibroblast Growth Factor-2 and the Invasive Potential in Urothelial Malignancies of the Bladder.成纤维细胞生长因子-2与膀胱尿路上皮恶性肿瘤的侵袭潜能
Cureus. 2023 Jan 24;15(1):e34147. doi: 10.7759/cureus.34147. eCollection 2023 Jan.
2
Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder.血管生成成分 VEGFA、FGF2、OPN 和 RHOC 在膀胱尿路上皮细胞癌中的作用。
Oncol Rep. 2012 Oct;28(4):1159-66. doi: 10.3892/or.2012.1948. Epub 2012 Aug 3.
3
High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.高级别T1期乳头状膀胱尿路上皮癌显示出明显的肿瘤周围退缩裂隙。
Pathol Oncol Res. 2018 Jul;24(3):567-574. doi: 10.1007/s12253-017-0279-2. Epub 2017 Jul 27.
4
Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms.细胞角蛋白20在尿路上皮肿瘤中作为预测和预后标志物的作用。
Cureus. 2022 Nov 17;14(11):e31607. doi: 10.7759/cureus.31607. eCollection 2022 Nov.
5
Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder.膀胱尿路上皮癌中ETS-1癌蛋白表达的免疫组织化学测定
Appl Immunohistochem Mol Morphol. 2012 Mar;20(2):153-8. doi: 10.1097/PAI.0b013e31821ba035.
6
Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence.GATA3在早期膀胱尿路上皮癌局部复发中的作用。
Cureus. 2023 Sep 10;15(9):e44998. doi: 10.7759/cureus.44998. eCollection 2023 Sep.
7
CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.膀胱尿路上皮癌不同分级和分期中CD 10的表达强度
J Coll Physicians Surg Pak. 2014 May;24(5):351-5.
8
Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.KAI1转移抑制基因表达降低是原发性pTa和pT1膀胱尿路上皮癌的复发预测指标。
Int J Urol. 2004 Feb;11(2):74-82. doi: 10.1111/j.1442-2042.2004.00752.x.
9
Growth pattern in superficial urothelial bladder carcinomas. Histological review and clinical relevance.浅表性膀胱癌的生长模式。组织学回顾与临床相关性。
Int Urol Nephrol. 2009 Dec;41(4):847-54. doi: 10.1007/s11255-009-9537-x. Epub 2009 Mar 12.
10
CD10 expression in urothelial carcinoma of the bladder.CD10 在膀胱尿路上皮癌中的表达。
Diagn Pathol. 2009 Nov 16;4:38. doi: 10.1186/1746-1596-4-38.

本文引用的文献

1
Cross-Talk Between Inflammation and Fibroblast Growth Factor 10 During Organogenesis and Pathogenesis: Lessons Learnt From the Lung and Other Organs.器官发生和发病机制过程中炎症与成纤维细胞生长因子10之间的相互作用:从肺和其他器官中获得的经验教训
Front Cell Dev Biol. 2021 May 31;9:656883. doi: 10.3389/fcell.2021.656883. eCollection 2021.
2
FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy.成纤维细胞生长因子 2 可改变巨噬细胞极化状态、肿瘤免疫和肿瘤生长,并且可以在放疗期间作为靶点。
Nat Commun. 2020 Aug 13;11(1):4064. doi: 10.1038/s41467-020-17914-x.
3
FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD).
成纤维细胞生长因子2,一种哮喘和慢性阻塞性肺疾病(COPD)中的免疫调节因子。
Front Cell Dev Biol. 2020 Apr 2;8:223. doi: 10.3389/fcell.2020.00223. eCollection 2020.
4
Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.鉴定胶质母细胞瘤癌症干细胞迁移所需的保守分子靶标。
Cell Death Dis. 2020 Feb 26;11(2):152. doi: 10.1038/s41419-020-2342-2.
5
The use of intravesical BCG in urothelial carcinoma of the bladder.膀胱内卡介苗在膀胱尿路上皮癌中的应用。
Ecancermedicalscience. 2019 Feb 26;13:905. doi: 10.3332/ecancer.2019.905. eCollection 2019.
6
Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis.B细胞发育标志物CD10在癌症进展和预后中的作用
Mol Biol Int. 2016;2016:4328697. doi: 10.1155/2016/4328697. Epub 2016 Nov 14.
7
Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.原发性上尿路尿路上皮癌患者根治性肾输尿管切除术后膀胱内复发治疗后膀胱结局的独立预测因素。
Ann Surg Oncol. 2014 Sep;21(9):3151-8. doi: 10.1245/s10434-014-3657-y. Epub 2014 Mar 29.
8
Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer.成纤维细胞生长因子受体 3 是膀胱癌的合理治疗靶点。
Mol Cancer Ther. 2013 Jul;12(7):1245-54. doi: 10.1158/1535-7163.MCT-12-1150. Epub 2013 May 8.
9
Functional screen of paracrine signals in breast carcinoma fibroblasts.乳腺癌成纤维细胞旁分泌信号的功能筛选。
PLoS One. 2012;7(10):e46685. doi: 10.1371/journal.pone.0046685. Epub 2012 Oct 8.
10
Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.基质肌纤维母细胞在浸润性乳腺癌中的作用:α-平滑肌肌动蛋白在基质中的表达与更差的临床结局相关。
Breast Cancer. 2012 Apr;19(2):170-6. doi: 10.1007/s12282-010-0234-5. Epub 2010 Oct 27.